Amarin Corp Plc (AMRN)

[Biobillionair]

Prevention of cardiovascular events. Reduced MI, reduced stroke (ischemic), reduced angioplasty/stent and hopefully the big kahuna reduction in overall deaths.

Secondary's: Should include: improvement in DM 1 & 2 based hgbA1c and reduced insulin needs, improved COPD, hypertension, weight.....

perhaps bigger secondaries like Alzheimer's, NASH, and dry eyes..........

BB